IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE

Clinical Immunology

Volumn 142, Issue 3, 2012, Pages 390-398

  Grönwall, Caroline ^a   Akhter, Ehtisham ^b   Oh, Cheongeun ^a   Burlingame, Rufus W ^c   Petri, Michelle ^b   Silverman, Gregg J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INOVA DIAGNOSTICS INC   (United States)

Author keywords

Cardiovascular disease; IgM; Natural antibodies; Renal disease; Systemic lupus erythematosus

Indexed keywords

ANTIGEN; CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA; IMMUNOGLOBULIN M ANTIBODY; MALONALDEHYDE ANTIGEN; PHOSPHORYLCHOLINE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY AND IMMUNOGLOBULIN STRUCTURE, FUNCTION AND PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HOMEOSTASIS; HUMAN; INNATE IMMUNITY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS; APOPTOSIS; AUTOANTIBODIES; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; KIDNEY DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MALONDIALDEHYDE; MIDDLE AGED; PHOSPHORYLCHOLINE;

EID: 84857362706     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.01.002     Document Type: Article

References (35)

1. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N. Engl. J. Med. 2008, 358:929-939.
2. Munoz L.E., Lauber K., Schiller M., Manfredi A.A., Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat. Rev. Rheumatol. 2010, 6:280-289.
3. Nagata S., Hanayama R., Kawane K. Autoimmunity and the clearance of dead cells. Cell 2010, 140:619-630.
4. Fadok V.A., Bratton D.L., Henson P.M. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J. Clin. Invest. 2001, 108:957-962.
5. Chen Y., Park Y.B., Patel E., Silverman G.J. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J. Immunol. 2009, 182:6031-6043.
6. Ogden C.A., Kowalewski R., Peng Y., Montenegro V., Elkon K.B. IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo. Autoimmunity 2005, 38:259-264.
7. Quartier P., Potter P.K., Ehrenstein M.R., Walport M.J., Botto M. Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur. J. Immunol. 2005, 35:252-260.
8. Chen Y., Khanna S., Goodyear C.S., Park Y.B., Raz E., Thiel S., Gronwall C., Vas J., Boyle D.L., Corr M., Kono D.H., Silverman G.J. Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J. Immunol. 2009, 183:1346-1359.
9. Binder C.J. Natural IgM antibodies against oxidation-specific epitopes. J. Clin. Immunol. 2010, 30(Suppl. 1):S56-S60.
10. Chou M.Y., Fogelstrand L., Hartvigsen K., Hansen L.F., Woelkers D., Shaw P.X., Choi J., Perkmann T., Backhed F., Miller Y.I., Horkko S., Corr M., Witztum J.L., Binder C.J. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J. Clin. Invest. 2009, 119:1335-1349.
11. Silverman G.J., Srikrishnan R., Germar K., Goodyear C.S., Andrews K.A., Ginzler E.M., Tsao B.P. Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients. Clin. Exp. Immunol. 2008, 153:102-116.
12. Cocca B.A., Cline A.M., Radic M.Z. Blebs and apoptotic bodies are B cell autoantigens. J. Immunol. 2002, 169:159-166.
13. Rovere P., Manfredi A.A., Vallinoto C., Zimmermann V.S., Fascio U., Balestrieri G., Ricciardi-Castagnoli P., Rugarli C., Tincani A., Sabbadini M.G. Dendritic cells preferentially internalize apoptotic cells opsonized by anti-beta2-glycoprotein I antibodies. J. Autoimmun. 1998, 11:403-411.
14. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725.
15. Petri M., Kim M.Y., Kalunian K.C., Grossman J., Hahn B.H., Sammaritano L.R., Lockshin M., Merrill J.T., Belmont H.M., Askanase A.D., McCune W.J., Hearth-Holmes M., Dooley M.A., Von Feldt J., Friedman A., Tan M., Davis J., Cronin M., Diamond B., Mackay M., Sigler L., Fillius M., Rupel A., Licciardi F., Buyon J.P. Combined oral contraceptives in women with systemic lupus erythematosus. N. Engl. J. Med. 2005, 353:2550-2558.
16. Dayal N.A., Gordon C., Tucker L., Isenberg D.A. The SLICC damage index: past, present and future. Lupus 2002, 11:261-265.
17. Manzi S., Meilahn E.N., Rairie J.E., Conte C.G., Medsger T.A., Jansen-McWilliams L., D'Agostino R.B., Kuller L.H. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am. J. Epidemiol. 1997, 145:408-415.
18. Bili A., Moss A.J., Francis C.W., Zareba W., Watelet L.F., Sanz I. Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators. Circulation 2000, 102:1258-1263.
19. Cohen D., Berger S.P., Steup-Beekman G.M., Bloemenkamp K.W., Bajema I.M. Diagnosis and management of the antiphospholipid syndrome. BMJ 2010, 340:c2541.
20. George D., Erkan D. Antiphospholipid syndrome. Prog. Cardiovasc. Dis. 2009, 52:115-125.
21. Amengual O., Atsumi T., Koike T. Specificities, properties, and clinical significance of antiprothrombin antibodies. Arthritis Rheum. 2003, 48:886-895.
22. Petri M. Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort. Lupus 2010, 19:419-423.
23. Brown M., Schiffman G., Rittenberg M.B. Subpopulations of antibodies to phosphocholine in human serum. J. Immunol. 1984, 132:1323-1328.
24. Guerin J., Casey E., Feighery C., Jackson J. Anti-Beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients. Autoimmunity 1999, 31:109-116.
25. Silverman G.J., Gronwall C., Vas J., Chen Y. Natural autoantibodies to apoptotic cell membranes regulate fundamental innate immune functions and suppress inflammation. Discov. Med. 2009, 8:151-156.
26. Su J., Hua X., Concha H., Svenungsson E., Cederholm A., Frostegard J. Natural antibodies against phosphorylcholine as potential protective factors in SLE. Rheumatology (Oxford) 2008, 47:1144-1150.
27. de Faire U., Su J., Hua X., Frostegard A., Halldin M., Hellenius M.L., Wikstrom M., Dahlbom I., Gronlund H., Frostegard J. Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism. J. Autoimmun. 2010, 34:73-79.
28. Fiskesund R., Stegmayr B., Hallmans G., Vikstrom M., Weinehall L., de Faire U., Frostegard J. Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden. Stroke 2010, 41:607-612.
29. Mehrani T., Petri M. IgM anti-beta2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus. J. Rheumatol. 2011, 38:450-453.
30. Li Q.Z., Xie C., Wu T., Mackay M., Aranow C., Putterman C., Mohan C. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J. Clin. Invest. 2005, 115:3428-3439.
31. Wang G., Pierangeli S.S., Papalardo E., Ansari G.A., Khan M.F. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum. 2010, 62:2064-2072.
32. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 2011, 11:34-46.
33. Baumgarth N., Herman O.C., Jager G.C., Brown L., Herzenberg L.A. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:2250-2255.
34. Griffin D.O., Holodick N.E., Rothstein T.L. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20(+)CD27(+)TD43(+)CD70(-) (vol 208, pg 67, 2011). J. Exp. Med. 2011, 208.
35. Burlingame R.W., Rubin R.L., Balderas R.S., Theofilopoulos A.N. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J. Clin. Invest. 1993, 91:1687-1696.